antonio pagliuca

King's College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

ORCID

Google Scholar

Articles (10)

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens

Article Link

Year:

2024

Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients

Article Link

Year:

2023

Foreword

Article Link

Year:

2022

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Article Link

Year:

2021

Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients.

Article Link

Year:

2020

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases

Article Link

Year:

2020

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)

Article Link

Year:

2020

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients

Article Link

Year:

2020

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

Article Link

Year:

2020

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

Article Link

Year:

2020

Collaborators (6)

Francesco Passamonti

ITALY

Lennard Lee

Associate Professor

University of Oxford

UNITED KINGDOM

Jan Novak

CZECH REPUBLIC

B. Deau

FRANCE

Jean Mbisa

Head, Antiviral Unit

UNITED KINGDOM

Isabel Regalado-Artamendi

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

antonio pagliuca

Research Interests

Explore related searches

Contact this professor

Articles (10)

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens

Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients

Foreword

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients.

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

Collaborators (6)

Francesco Passamonti

Lennard Lee

Jan Novak

B. Deau

Jean Mbisa

Isabel Regalado-Artamendi

How do I reach out?

Meet Kite AI